(RTTNews) - Myriad Genetics, Inc. (MYGN), a genetic testing and precision medicine company, on Wednesday announced its groundbreaking study results on the Prequel Prenatal Screen with AMPLIFY ...
Assenagon Asset Management S.A.’s holdings in Myriad Genetics were worth $2,255,000 as of its most recent SEC filing. A number of other hedge funds have also modified their holdings of the company.
ALEXANDRIA, Va., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Motley Fool Asset Management (“MFAM"), an SEC-registered investment adviser with approximately $2.6 billion in assets under management in ...
Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing. The ...
The advantages of doing so can be immediate, such as avoiding the high management fees that some ... There are five asset classes for fixed-income investments: 1) government-issued securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results